References
Global tuberculosis control 2010. Geneva: World Health Organization, 2010
Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization, 2010
Albanna AS, Menzies D. Drug-resistant tuberculosis: what are the treatment options? Drugs 2011 May; 71(7): 815–25
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, et al. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis 2004 Jan 15; 38(2): 280–3
Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Geneva: World Health Organization, 2008
Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization, 2010
Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3: S231–79
Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med 2009 Sep; 6(9): e1000146
Fitzpatrick C, Floyd K. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 2012; 30(1): 63–80
Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009 Apr; 33(4): 871–81
Kim SJ, Espinal MA, Abe C, et al. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis 2004 Sep; 8(9): 1157–8
Dheda K, Warren RM, Zumla A, et al. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am 2010 Sep; 24(3): 705–25
Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994 Apr 28; 330(17): 1179–84
Mathew JL. Fixed dose drug combination for treatment of tuberculosis. Indian Pediatr 2009 Oct; 46(10): 877–80
Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003 Jan 9; 348(2): 119–28
Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010 May 22; 375(9728): 1798–807
Pomerantz BJ, Cleveland Jr JC, Olson HK, et al. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001 Mar; 121(3): 448–53
Rights and permissions
About this article
Cite this article
Ensure a comprehensive approach when treating drug-resistant tuberculosis. Drugs Ther Perspect 28, 15–18 (2012). https://doi.org/10.2165/11606270-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11606270-000000000-00000